These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 23807779)

  • 21. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.
    Matsuda K; Yamauchi K; Matsumoto T; Sano K; Yamaoka Y; Ota H
    Scand J Gastroenterol; 2008 Jan; 43(1):25-33. PubMed ID: 18938748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma.
    Tsai JH; Lin YL; Cheng YC; Chen CC; Lin LI; Tseng LH; Cheng ML; Liau JY; Jeng YM
    Mod Pathol; 2015 Feb; 28(2):268-78. PubMed ID: 25081749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
    Duruisseaux M; Antoine M; Rabbe N; Rodenas A; Mc Leer-Florin A; Lacave R; Poulot V; Duchêne B; Van Seuningen I; Cadranel J; Wislez M
    Lung Cancer; 2017 Jul; 109():92-100. PubMed ID: 28577958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium.
    Babu SD; Jayanthi V; Devaraj N; Reis CA; Devaraj H
    Mol Cancer; 2006 Mar; 5():10. PubMed ID: 16545139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.
    Betge J; Schneider NI; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
    Virchows Arch; 2016 Sep; 469(3):255-65. PubMed ID: 27298226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer.
    Lee HK; Kwon MJ; Seo J; Kim JW; Hong M; Park HR; Min SK; Choe JY; Ra YJ; Jang SH; Hwang YI; Kim HY; Min KW
    Pathol Res Pract; 2019 Mar; 215(3):459-465. PubMed ID: 30580903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
    Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
    Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.
    Warson C; Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Ectors NL; Dekker J
    Hum Pathol; 2002 Jun; 33(6):660-8. PubMed ID: 12152167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer.
    Kawasaki T; Ohnishi M; Suemoto Y; Kirkner GJ; Liu Z; Yamamoto H; Loda M; Fuchs CS; Ogino S
    Mod Pathol; 2008 Feb; 21(2):150-8. PubMed ID: 18084250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.
    Reis CA; David L; Correa P; Carneiro F; de Bolós C; Garcia E; Mandel U; Clausen H; Sobrinho-Simões M
    Cancer Res; 1999 Mar; 59(5):1003-7. PubMed ID: 10070955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide.
    Myerscough N; Sylvester PA; Warren BF; Biddolph S; Durdey P; Thomas MG; Carlstedt I; Corfield AP
    Glycoconj J; 2001; 18(11-12):907-14. PubMed ID: 12820724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
    Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM
    Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1.
    Perrais M; Pigny P; Copin MC; Aubert JP; Van Seuningen I
    J Biol Chem; 2002 Aug; 277(35):32258-67. PubMed ID: 12077147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
    Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
    Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.
    Alos L; Lujan B; Castillo M; Nadal A; Carreras M; Caballero M; de Bolos C; Cardesa A
    Am J Surg Pathol; 2005 Jun; 29(6):806-13. PubMed ID: 15897748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
    Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
    Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas.
    Losi L; Scarselli A; Benatti P; Ponz de Leon M; Roncucci L; Pedroni M; Borghi F; Lamberti I; Rossi G; Marino M; Ponti G; Zangardi G; Menigatti M; Di Gregorio C
    Pathol Res Pract; 2004; 200(5):371-7. PubMed ID: 15239345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
    J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.